Open Access

[Corrigendum] HORMAD1 promotes docetaxel resistance in triple negative breast cancer by enhancing DNA damage tolerance

  • Authors:
    • Beige Zong
    • Lu Sun
    • Yang Peng
    • Yihua Wang
    • Yu Yu
    • Jinwei Lei
    • Yingzi Zhang
    • Shipeng Guo
    • Kang Li
    • Shengchun Liu
  • View Affiliations

  • Published online on: July 19, 2021     https://doi.org/10.3892/or.2021.8146
  • Article Number: 195
  • Copyright : © Zong et al. This is an open access article distributed under the terms of Creative Commons Attribution License [CC BY 4.0].

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )


Article

Oncol Rep 46: Article no. [Related article:] 138, 2021; DOI: 10.3892/or.2021.8089

Following the publication of this article, the authors realized that the published version of Fig. 4A contained an erroneous label; essentially, the information purported to relate to experiments having been performed with docetaxel should not have been included in this figure.

The correctly labelled version of Fig. 4 is shown with the remainder of Fig. 4 on the next page. This change does not affect the data shown in the paper, and the text in the published article did accurately describe the information shown in this figure. The authors sincerely apologize for the error that was introduced during the preparation of this figure, and thank the Editor for allowing them the opportunity to publish a Corrigendum. Furthermore, they regret any inconvenience caused.

Related Articles

Journal Cover

September-2021
Volume 46 Issue 3

Print ISSN: 1021-335X
Online ISSN:1791-2431

Sign up for eToc alerts

Recommend to Library

Copy and paste a formatted citation
x
Spandidos Publications style
Zong B, Sun L, Peng Y, Wang Y, Yu Y, Lei J, Zhang Y, Guo S, Li K, Liu S, Liu S, et al: [Corrigendum] HORMAD1 promotes docetaxel resistance in triple negative breast cancer by enhancing DNA damage tolerance. Oncol Rep 46: 195, 2021
APA
Zong, B., Sun, L., Peng, Y., Wang, Y., Yu, Y., Lei, J. ... Liu, S. (2021). [Corrigendum] HORMAD1 promotes docetaxel resistance in triple negative breast cancer by enhancing DNA damage tolerance. Oncology Reports, 46, 195. https://doi.org/10.3892/or.2021.8146
MLA
Zong, B., Sun, L., Peng, Y., Wang, Y., Yu, Y., Lei, J., Zhang, Y., Guo, S., Li, K., Liu, S."[Corrigendum] HORMAD1 promotes docetaxel resistance in triple negative breast cancer by enhancing DNA damage tolerance". Oncology Reports 46.3 (2021): 195.
Chicago
Zong, B., Sun, L., Peng, Y., Wang, Y., Yu, Y., Lei, J., Zhang, Y., Guo, S., Li, K., Liu, S."[Corrigendum] HORMAD1 promotes docetaxel resistance in triple negative breast cancer by enhancing DNA damage tolerance". Oncology Reports 46, no. 3 (2021): 195. https://doi.org/10.3892/or.2021.8146